Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists

Latest VR Adviser, LLC Stock Portfolio

$2.10Billion

Equity Portfolio Value
Last Reported on: 15 May, 2024

About VR Adviser, LLC and it’s 13F Hedge Fund Stock Holdings

VR Adviser, LLC is a hedge fund based in NEW YORK, NY. On 30-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $2.4 Billions. In it's latest 13F Holdings report, VR Adviser, LLC reported an equity portfolio of $2.1 Billions as of 31 Mar, 2024.

The top stock holdings of VR Adviser, LLC are , FDMT, OCUL. The fund has invested 26.9% of it's portfolio in APOGEE THERAPEUTICS INC and 6.7% of portfolio in 4D MOLECULAR THERAPEUTICS IN.

The fund managers got completely rid off RAYZEBIO INC, AMBRX BIOPHARMA INC (AMAM) and RHYTHM PHARMACEUTICALS INC (RYTM) stocks. They significantly reduced their stock positions in CELCUITY INC (CELC), CABALETTA BIO INC (CABA) and TERNS PHARMACEUTICALS INC (TERN). VR Adviser, LLC opened new stock positions in ENGENE HOLDINGS INC, EDGEWISE THERAPEUTICS INC (EWTX) and AQUESTIVE THERAPEUTICS INC (AQST). The fund showed a lot of confidence in some stocks as they added substantially to DIANTHUS THERAPEUTICS INC, PRAXIS PRECISION MEDICINES I (PRAX) and ORIC PHARMACEUTICALS INC (ORIC).

New Buys

Ticker$ Bought
ENGENE HOLDINGS INC43,491,000
EDGEWISE THERAPEUTICS INC33,163,600
AQUESTIVE THERAPEUTICS INC23,666,700
ADVERUM BIOTECHNOLOGIES INC22,007,800
IMMATICS N.V18,392,500
CG ONCOLOGY INC15,365,000
CENTURY THERAPEUTICS INC14,233,500
TENAYA THERAPEUTICS INC8,135,560

New stocks bought by VR Adviser, LLC

Additions

Ticker% Inc.
DIANTHUS THERAPEUTICS INC125
PRAXIS PRECISION MEDICINES I99.68
ORIC PHARMACEUTICALS INC80.97
OCULAR THERAPEUTIX INC64.13
KALVISTA PHARMACEUTICALS INC52.7
APPLIED THERAPEUTICS INC45.2
ENLIVEN THERAPEUTICS INC36.26
ABIVAX SA34.77

Additions to existing portfolio by VR Adviser, LLC

Reductions

Ticker% Reduced
CELCUITY INC-48.56
CABALETTA BIO INC-39.00
TERNS PHARMACEUTICALS INC-24.17
MERUS N V-16.67
TAYSHA GENE THERAPIES INC-13.57
SPYRE THERAPEUTICS INC-8.47

VR Adviser, LLC reduced stake in above stock

Sold off

Ticker$ Sold
RAYZEBIO INC-250,574,000
SAVARA INC-16,450,000
AMBRX BIOPHARMA INC-29,476,800
GH RESEARCH PLC-7,646,300
MILESTONE PHARMACEUTICALS IN-1,544,830
ADVERUM BIOTECHNOLOGIES INC-3,875,070
RHYTHM PHARMACEUTICALS INC-22,800,300

VR Adviser, LLC got rid off the above stocks

Current Stock Holdings of VR Adviser, LLC

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions
ADVMADVERUM BIOTECHNOLOGIES INC1.051,556,42022,007,800NEW
ADVMADVERUM BIOTECHNOLOGIES INC0.000.000.00SOLD OFF-100
AGLESPYRE THERAPEUTICS INC3.922,171,78082,375,700REDUCED-8.47
AMAMAMBRX BIOPHARMA INC0.000.000.00SOLD OFF-100
APLTAPPLIED THERAPEUTICS INC2.949,075,00061,710,000ADDED45.2
AQSTAQUESTIVE THERAPEUTICS INC1.135,555,56023,666,700NEW
ARVNARVINAS INC1.23627,78825,915,100UNCHANGED0.00
ATXSASTRIA THERAPEUTICS INC2.423,608,64050,791,700ADDED11.87
CABACABALETTA BIO INC1.271,563,95026,681,000REDUCED-39.00
CELCCELCUITY INC1.00970,00020,952,000REDUCED-48.56
COGTCOGENT BIOSCIENCES INC1.645,129,17034,468,000ADDED9.5
DYNDYNE THERAPEUTICS INC2.942,173,91061,717,400UNCHANGED0.00
EWTXEDGEWISE THERAPEUTICS INC1.581,818,18033,163,600NEW
EYPTEYEPOINT PHARMACEUTICALS INC0.25250,0005,167,500UNCHANGED0.00
FDMT4D MOLECULAR THERAPEUTICS IN6.674,400,000140,184,000ADDED28.5
GHRSGH RESEARCH PLC0.000.000.00SOLD OFF-100
HLVXHILLEVAX INC1.642,075,00034,507,200UNCHANGED0.00
IMTXIMMATICS N.V0.881,750,00018,392,500NEW
IPSCCENTURY THERAPEUTICS INC0.683,405,13014,233,500NEW
KALVKALVISTA PHARMACEUTICALS INC3.536,249,73074,121,800ADDED52.7
LYRALYRA THERAPEUTICS INC0.762,576,09016,023,300ADDED0.02
MISTMILESTONE PHARMACEUTICALS IN0.000.000.00SOLD OFF-100
MRSNMERSANA THERAPEUTICS INC2.4111,328,00050,749,400UNCHANGED0.00
MRUSMERUS N V3.841,790,21080,613,300REDUCED-16.67
OCULOCULAR THERAPEUTIX INC5.5312,762,500116,138,000ADDED64.13
OLMAOLEMA PHARMACEUTICALS INC0.0477,042872,115UNCHANGED0.00
ORICORIC PHARMACEUTICALS INC2.874,394,53060,424,700ADDED80.97
PHVSPHARVARIS N V3.733,395,61078,472,500UNCHANGED0.00
PRAXPRAXIS PRECISION MEDICINES I2.05706,12643,087,800ADDED99.68
RYTMRHYTHM PHARMACEUTICALS INC0.000.000.00SOLD OFF-100
SVRASAVARA INC0.000.000.00SOLD OFF-100
TERNTERNS PHARMACEUTICALS INC1.063,410,06022,370,000REDUCED-24.17
TNYATENAYA THERAPEUTICS INC0.391,555,5608,135,560NEW
TRVITREVI THERAPEUTICS INC0.563,422,68011,808,200ADDED0.01
TSHATAYSHA GENE THERAPIES INC1.239,000,00025,830,000REDUCED-13.57
VRDNVIRIDIAN THERAPEUTICS INC3.233,882,67067,985,600ADDED0.00
APOGEE THERAPEUTICS INC26.858,493,320564,381,000UNCHANGED0.00
ENLIVEN THERAPEUTICS INC3.374,026,33070,823,200ADDED36.26
DIANTHUS THERAPEUTICS INC2.992,094,37062,831,200ADDED125
ENGENE HOLDINGS INC2.072,565,84043,491,000NEW
ABIVAX SA0.921,345,78019,244,700ADDED34.77
CG ONCOLOGY INC0.73350,00015,365,000NEW
MINERALYS THERAPEUTICS INC0.34555,5547,172,200NEW
ACELYRIN INC0.30937,1136,325,510UNCHANGED0.00
RAYZEBIO INC0.000.000.00SOLD OFF-100